154 related articles for article (PubMed ID: 11420805)
1. Risk structure compensation in Germany's statutory health insurance.
Busse R
Eur J Public Health; 2001 Jun; 11(2):174-7. PubMed ID: 11420805
[TBL] [Abstract][Full Text] [Related]
2. Needs for further improvement: risk adjustment in the German health insurance system.
Buchner F; Wasem J
Health Policy; 2003 Jul; 65(1):21-35. PubMed ID: 12818743
[TBL] [Abstract][Full Text] [Related]
3. [Switching sickness funds and risk compensation mechanisms in the statutory health insurance system in Germany--empirical results from the cooperative health research in the region of Augsburg (KORA)].
Werner A; Reitmeir P; John J
Gesundheitswesen; 2005 Aug; 67 Suppl 1():S158-66. PubMed ID: 16032535
[TBL] [Abstract][Full Text] [Related]
4. Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition.
Busse R; Blümel M; Knieps F; Bärnighausen T
Lancet; 2017 Aug; 390(10097):882-897. PubMed ID: 28684025
[TBL] [Abstract][Full Text] [Related]
5. Disease management programs in Germany's statutory health insurance system.
Busse R
Health Aff (Millwood); 2004; 23(3):56-67. PubMed ID: 15160803
[TBL] [Abstract][Full Text] [Related]
6. [Susceptibility to strategy of the drug component of the IPHCC+RxGroups classification system in a risk-adjusted morbidity compensation scheme--a conceptional and data-supported analysis].
Behrend C; Felder S; Busse R
Gesundheitswesen; 2007 Jan; 69(1):1-10. PubMed ID: 17347926
[TBL] [Abstract][Full Text] [Related]
7. [Options for a future risc structure compensation in Germany].
Greiner W
Gesundheitswesen; 2006 Jul; 68(7):442-8. PubMed ID: 16868871
[TBL] [Abstract][Full Text] [Related]
8. Risk selection in the German public health insurance system.
Nuscheler R; Knaus T
Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of selection inventives for health insurances after introduction of the morbidity-oriented risk compensation scheme: an empirical analysis].
Lüngen M; Drabik A; Büscher G; Passon A; Siegel M; Stock S
Gesundheitswesen; 2010 Nov; 72(11):790-6. PubMed ID: 20104447
[TBL] [Abstract][Full Text] [Related]
10. Universal health insurance and high-risk groups in West Germany: implications for U.S. health policy.
Wysong JA; Abel T
Milbank Q; 1990; 68(4):527-60. PubMed ID: 2292990
[TBL] [Abstract][Full Text] [Related]
11. [Competition among health insurers from the perspective of a statutory health insurance company].
Fischer B
Z Evid Fortbild Qual Gesundhwes; 2009; 103(10):635-8; discussion 643. PubMed ID: 20120192
[TBL] [Abstract][Full Text] [Related]
12. Optional deductibles in social health insurance systems: findings from Germany.
Pütz C; Hagist C
Eur J Health Econ; 2006 Dec; 7(4):225-30. PubMed ID: 16802119
[TBL] [Abstract][Full Text] [Related]
13. On the calculation of the Israeli risk adjustment rates.
Shmueli A
Eur J Health Econ; 2015 Apr; 16(3):271-7. PubMed ID: 24577558
[TBL] [Abstract][Full Text] [Related]
14. Determinants of health care utilization by German sickness fund members--with application to risk adjustment.
Breyer F; Heineck M; Lorenz N
Health Econ; 2003 May; 12(5):367-76. PubMed ID: 12720254
[TBL] [Abstract][Full Text] [Related]
15. Introducing risk adjustment and free health plan choice in employer-based health insurance: Evidence from Germany.
Pilny A; Wübker A; Ziebarth NR
J Health Econ; 2017 Dec; 56():330-351. PubMed ID: 29248059
[TBL] [Abstract][Full Text] [Related]
16. Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands.
Gress S; Groenewegen P; Kerssens J; Braun B; Wasem J
Health Policy; 2002 Jun; 60(3):235-54. PubMed ID: 11965333
[TBL] [Abstract][Full Text] [Related]
17. [Expenditures of The German Statutory Health Insurance for Health Promotion and Disease Prevention 2012-2017: Positive Effects Due To The Disease Prevention Law?].
Bödeker W; Moebus S
Gesundheitswesen; 2020 Mar; 82(3):282-287. PubMed ID: 30822817
[TBL] [Abstract][Full Text] [Related]
18. [Market Concentration in the Statutory Health Insurance of Germany since the Introduction of Free Choice of Sickness Funds].
Götze R
Gesundheitswesen; 2016 Nov; 78(11):715-720. PubMed ID: 25760099
[No Abstract] [Full Text] [Related]
19. Implementing prospective budgeting for Dutch sickness funds.
Okma KG; Poelert JD
Eur J Public Health; 2001 Jun; 11(2):178-81. PubMed ID: 11420806
[TBL] [Abstract][Full Text] [Related]
20. Forming and reforming the market for third-party purchasing of health care: a German perspective.
Graf von der Schulenburg JM
Soc Sci Med; 1994 Nov; 39(10):1473-81. PubMed ID: 7863359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
